Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Respiratory Syncyctial Virus Vaccines
Interventions
OTHER

Data collection

The previous study has used four primary data sources: the General Practice Research Data (GPRD \[recently re-named Clinical Practice Research Datalink (CPRD)\], for mild outcomes), the Hospital Episode Statistics database (HES, for hospitalizations), the Office of National Statistics mortality database (ONS, for mortality), and weekly virology data from the Health Protection Agency (HPA). The extracted data are referred to as the EPI-FLU-018 BOD UK DB database. Weekly time series will be generated to estimate the RSV burden and characterize it in terms of incidence of GP consultations, hospitalizations and deaths for each of the respiratory and non-respiratory outcomes (including GP antibiotic prescriptions), stratified by age and risk group.

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Sage Analytica

INDUSTRY

lead

GlaxoSmithKline

INDUSTRY

NCT01706302 - Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009 | Biotech Hunter | Biotech Hunter